Align Technology's second quarter is a record wrapped in a transition. Total revenue came in at $1.06 billion, up 4.3% year over year and the highest the company has ever reported, as the Invisalign clear-aligner franchise grew 8.2% on 7.4% volume growth. But that headline conceals a deliberate, boardroom-driven remaking of the business. The systems and services arm - the iTero scanners and exocad CAD/CAM software - fell 10.8% year over year, not because demand collapsed but because management is steering scanner sales toward lower-priced machines, leasing, and rentals that push revenue recognition into the future. And the quarter arrived inside an activist turn: the same day results were released, Align announced three new independent directors, a strategic and operating model review backed by a major consulting firm, and a raised 2026 buyback, all following "constructive discussions" with Elliott Investment Management.
The bottom line moved sideways, and the reasons matter. GAAP diluted earnings per share fell to $1.51 from $1.72 a year earlier, hit by a $37.5 million UK VAT liability and unfavorable currency. Exclude those, and non-GAAP diluted EPS rose to $2.64 from $2.49. Management framed the scanner de-emphasis as a deliberate trade of near-term hardware revenue for durable, higher-margin treatment volume and recurring subscription income later. The stock - which bottomed near $122 last September, ran to a $200.44 peak in April, and sits near $173 - is being asked to trust that the pivot, plus the activist-driven push for margin, converts compounding volumes into compounding profits.